Lena Öhman
Title
Cited by
Cited by
Year
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
IB Jeffery, PW O'toole, L Öhman, MJ Claesson, J Deane, EMM Quigley, ...
Gut 61 (7), 997-1006, 2012
7302012
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
L Öhman, M Simrén
Nature reviews Gastroenterology & hepatology 7 (3), 163, 2010
6232010
Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome
J Tap, M Derrien, H Törnblom, R Brazeilles, S Cools-Portier, J Doré, ...
Gastroenterology 152 (1), 111-123. e8, 2017
3162017
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
C Casen, HC Vebø, M Sekelja, FT Hegge, MK Karlsson, E Ciemniejewska, ...
Alimentary pharmacology & therapeutics 42 (1), 71-83, 2015
2172015
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
N Holmén, A Lundgren, S Lundin, AM Bergin, A Rudin, H Sjövall, ...
Inflammatory bowel diseases 12 (6), 447-456, 2006
1932006
The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis
A Lasson, PO Stotzer, L Öhman, S Isaksson, M Sapnara, H Strid
Journal of Crohn's and Colitis 9 (1), 26-32, 2015
1902015
T-cell activation in patients with irritable bowel syndrome
L Öhman, S Isaksson, AC Lindmark, I Posserud, PO Stotzer, H Strid, ...
Official journal of the American College of Gastroenterology| ACG 104 (5 …, 2009
1822009
Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome–a randomized, double‐blind, controlled study
M Simrén, L Öhman, J Olsson, U Svensson, K Ohlson, I Posserud, H Strid
Alimentary pharmacology & therapeutics 31 (2), 218-227, 2010
1742010
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome
L Öhman, M Simren
Digestive and liver disease 39 (3), 201-215, 2007
1742007
Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis
M Bashashati, N Rezaei, A Shafieyoun, DP McKernan, L Chang, ...
Neurogastroenterology & Motility 26 (7), 1036-1048, 2014
1582014
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS
L Öhman, H Törnblom, M Simrén
Nature reviews Gastroenterology & hepatology 12 (1), 36-49, 2015
1472015
Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs
SMP Bennet, L Böhn, S Störsrud, T Liljebo, L Collin, P Lindfors, ...
Gut 67 (5), 872-881, 2018
1392018
Gut microbiota as potential orchestrators of irritable bowel syndrome
SMP Bennet, L Öhman, M Simrén
Gut and liver 9 (3), 318, 2015
1372015
A controlled study of colonic immune activity and β7+ blood T lymphocytes in patients with irritable bowel syndrome
L Öhman, S Isaksson, A Lundgren, M Simrén, H Sjövall
Clinical Gastroenterology and Hepatology 3 (10), 980-986, 2005
1262005
Intestinal microbiota and its role in irritable bowel syndrome (IBS)
L Öhman, M Simrén
Current gastroenterology reports 15 (5), 323, 2013
1192013
The microbiota link to irritable bowel syndrome: an emerging story
IB Jeffery, EMM Quigley, L Öhman, M Simrén, PW O'Toole
Gut Microbes 3 (6), 572-576, 2012
1052012
Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies
B Ahluwalia, L Moraes, MK Magnusson, L Öhman
Scandinavian journal of gastroenterology 53 (4), 379-389, 2018
982018
Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad
B Ahluwalia, MK Magnusson, L Öhman
Scandinavian journal of gastroenterology 52 (11), 1185-1193, 2017
942017
Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure
E Kalaitzakis, I Bosaeus, L Öhman, E Björnsson
The American journal of clinical nutrition 85 (3), 808-815, 2007
922007
Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation
MK Magnusson, SF Brynjólfsson, A Dige, H Uronen-Hansson, ...
Mucosal immunology 9 (1), 171-182, 2016
852016
The system can't perform the operation now. Try again later.
Articles 1–20